Novartis (NVS) News Today $109.04 +1.73 (+1.61%) As of 10:57 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Novartis AG (NYSE:NVS) Shares Sold by Bryn Mawr Capital Management LLCBryn Mawr Capital Management LLC reduced its stake in Novartis AG (NYSE:NVS - Free Report) by 22.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,873 shares of the company's stock after selling 2,911 shaFebruary 21 at 4:36 AM | marketbeat.comNovartis AG (NVS): Among the Best Global Stocks to Buy According to Hedge FundsFebruary 20 at 8:49 PM | msn.comNovartis AG (NYSE:NVS) Shares Bought by Venturi Wealth Management LLCVenturi Wealth Management LLC raised its stake in Novartis AG (NYSE:NVS - Free Report) by 105.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 11,631 shares of the company's stock after purchasing an aFebruary 19 at 5:07 AM | marketbeat.comAllspring Global Investments Holdings LLC Purchases 55,581 Shares of Novartis AG (NYSE:NVS)Allspring Global Investments Holdings LLC boosted its position in Novartis AG (NYSE:NVS - Free Report) by 129.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 98,412 shares of the company's stock after purchasing an additioFebruary 19 at 3:38 AM | marketbeat.comD.A. Davidson & CO. Cuts Position in Novartis AG (NYSE:NVS)D.A. Davidson & CO. lowered its position in shares of Novartis AG (NYSE:NVS - Free Report) by 4.6% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 464,582 shares of the company's stock after selling 22,558 shares during the quarter. D.A. Davidson & CO.'sFebruary 18 at 5:41 AM | marketbeat.comTruist Financial Corp Grows Holdings in Novartis AG (NYSE:NVS)Truist Financial Corp boosted its holdings in shares of Novartis AG (NYSE:NVS - Free Report) by 3.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 771,655 shares of the company's stock after acquiringFebruary 18 at 5:25 AM | marketbeat.comPrincipal Financial Group Inc. Decreases Holdings in Novartis AG (NYSE:NVS)Principal Financial Group Inc. lowered its holdings in Novartis AG (NYSE:NVS - Free Report) by 1.7% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 2,426,926 shares of the company's stock after selling 42,642 shares during the quarter. PrinFebruary 18 at 4:59 AM | marketbeat.comAmericana Partners LLC Cuts Position in Novartis AG (NYSE:NVS)Americana Partners LLC lessened its position in Novartis AG (NYSE:NVS - Free Report) by 9.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 25,491 shares of the company's stock after selling 2,527February 18 at 4:50 AM | marketbeat.comStrategic Financial Concepts LLC Buys New Position in Novartis AG (NYSE:NVS)Strategic Financial Concepts LLC purchased a new position in shares of Novartis AG (NYSE:NVS - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 26,622 shares of the company's stock, valued at approximately $February 18 at 4:22 AM | marketbeat.comPrincipal Securities Inc. Grows Position in Novartis AG (NYSE:NVS)Principal Securities Inc. increased its position in shares of Novartis AG (NYSE:NVS - Free Report) by 10.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 28,757 shares of the company's stock after purchasing anFebruary 18 at 4:14 AM | marketbeat.comAlphaCentric Advisors LLC Invests $1.53 Million in Novartis AG (NYSE:NVS)AlphaCentric Advisors LLC acquired a new position in shares of Novartis AG (NYSE:NVS - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 15,719 shares of the company's stock, valued at approximFebruary 17, 2025 | marketbeat.comNovartis AG (NYSE:NVS) Shares Bought by Csenge Advisory GroupCsenge Advisory Group increased its holdings in Novartis AG (NYSE:NVS - Free Report) by 63.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 16,395 shares of the company's stock after purchasing an additional 6,369 shares durinFebruary 17, 2025 | marketbeat.comAllworth Financial LP Acquires 91,866 Shares of Novartis AG (NYSE:NVS)Allworth Financial LP raised its holdings in shares of Novartis AG (NYSE:NVS - Free Report) by 2,354.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 95,768 shares of the company's stock after purchasing an additional 91,866 sharFebruary 17, 2025 | marketbeat.comBlue Trust Inc. Cuts Holdings in Novartis AG (NYSE:NVS)Blue Trust Inc. trimmed its holdings in shares of Novartis AG (NYSE:NVS - Free Report) by 36.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,086 shares of the company's stock after sellingFebruary 17, 2025 | marketbeat.comRoxbury Financial LLC Purchases New Shares in Novartis AG (NYSE:NVS)Roxbury Financial LLC purchased a new stake in Novartis AG (NYSE:NVS - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 3,769 shares of the company's stock, valued at approximately $399,000. Other institutional iFebruary 16, 2025 | marketbeat.comHickory Asset Management Inc. Invests $349,000 in Novartis AG (NYSE:NVS)Hickory Asset Management Inc. bought a new position in shares of Novartis AG (NYSE:NVS - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund bought 3,582 shares of the company's stock, valued at approximately $349,000. Several other large investors alsFebruary 16, 2025 | marketbeat.comBXM Wealth LLC Makes New $487,000 Investment in Novartis AG (NYSE:NVS)BXM Wealth LLC purchased a new position in Novartis AG (NYSE:NVS - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 5,005 shares of the company's stock, valued at approximately $February 16, 2025 | marketbeat.comABC Arbitrage SA Makes New Investment in Novartis AG (NYSE:NVS)ABC Arbitrage SA purchased a new position in Novartis AG (NYSE:NVS - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 203,424 shares of the company's stock, valued at approximately $19,795,0February 16, 2025 | marketbeat.com3,096 Shares in Novartis AG (NYSE:NVS) Acquired by TigerOak Management L.L.C.TigerOak Management L.L.C. acquired a new position in shares of Novartis AG (NYSE:NVS - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 3,096 shares of the company's stock, valued at approximately $301,000. Other hedge fundsFebruary 16, 2025 | marketbeat.comNovartis: Strong Execution With A P/E DiscountFebruary 16, 2025 | seekingalpha.comChevy Chase Trust Holdings LLC Has $112.99 Million Stock Holdings in Novartis AG (NYSE:NVS)Chevy Chase Trust Holdings LLC boosted its position in Novartis AG (NYSE:NVS - Free Report) by 4.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,161,139 shares of the company's stock after buying an additional 52,044 shares duringFebruary 15, 2025 | marketbeat.comNovartis AG (NYSE:NVS) Shares Bought by V Square Quantitative Management LLCV Square Quantitative Management LLC lifted its stake in shares of Novartis AG (NYSE:NVS - Free Report) by 29.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 11,173 shares of the company's stock after buying an additional 2,February 15, 2025 | marketbeat.comVan ECK Associates Corp Has $31.88 Million Holdings in Novartis AG (NYSE:NVS)Van ECK Associates Corp raised its position in shares of Novartis AG (NYSE:NVS - Free Report) by 5.4% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 327,614 shares of the company's stock after purchasing an additional 16,901 shares during the quarter. Van ECFebruary 15, 2025 | marketbeat.comNovartis (NYSE:NVS) Coverage Initiated at Morgan StanleyFebruary 15, 2025 | americanbankingnews.comNovartis: Just What The Doctor OrderedFebruary 14, 2025 | seekingalpha.comIs Novartis AG (NVS) the Best Foreign Dividend Stock to Buy According to Analysts?February 14, 2025 | insidermonkey.comNovartis’ Ianalumab granted FDA orphan designationFebruary 14, 2025 | markets.businessinsider.comUBS Downgrades Novartis AG - Depositary Receipt () (NVS)February 14, 2025 | msn.comNovartis downgraded to Neutral from Buy at UBSFebruary 13, 2025 | markets.businessinsider.comUBS Group Reiterates "Neutral" Rating for Novartis (NYSE:NVS)UBS Group reiterated a "neutral" rating on shares of Novartis in a report on Thursday.February 13, 2025 | marketbeat.comPortfolio Design Labs LLC Makes New $277,000 Investment in Novartis AG (NYSE:NVS)Portfolio Design Labs LLC acquired a new position in Novartis AG (NYSE:NVS - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 2,842 shares of the company's stock, valued at approxFebruary 13, 2025 | marketbeat.comNovartis initiated with an Underweight at Morgan StanleyFebruary 13, 2025 | markets.businessinsider.comMorgan Stanley cuts Novartis stock rating to UnderweightFebruary 13, 2025 | msn.com12,237 Shares in Novartis AG (NYSE:NVS) Bought by Kentucky Trust CoKentucky Trust Co acquired a new position in shares of Novartis AG (NYSE:NVS - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 12,237 shares of the company's stock, valued at approximately $1,191,000. OtheFebruary 12, 2025 | marketbeat.comMorgan Stanley Initiates Coverage on Novartis (NYSE:NVS)Morgan Stanley started coverage on shares of Novartis in a report on Wednesday. They issued an "underweight" rating on the stock.February 12, 2025 | marketbeat.comNovartis To Beef Up Heart Disease Offering With $3 Billion Blackstone-Backed Anthos Therapeutics DealFebruary 12, 2025 | benzinga.comNovartis to buy Anthos Therapeutics for up to $3.1BFebruary 11, 2025 | msn.comNovartis agrees to acquire Anthos for up to $3.1BFebruary 11, 2025 | markets.businessinsider.comNovartis Strikes Up to $3.1 Billion Deal to Buy Anthos TherapeuticsFebruary 11, 2025 | msn.comHold Rating for Novartis AG Due to Limited Potential of Abelacimab Despite Acquisition of Anthos TherapeuticsFebruary 11, 2025 | tipranks.comCambiar Investors LLC Sells 3,634 Shares of Novartis AG (NYSE:NVS)Cambiar Investors LLC decreased its stake in Novartis AG (NYSE:NVS - Free Report) by 2.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 121,975 shares of the company's stock after selling 3,634 shares during the periFebruary 11, 2025 | marketbeat.comEntropy Technologies LP Buys Shares of 9,938 Novartis AG (NYSE:NVS)Entropy Technologies LP purchased a new position in shares of Novartis AG (NYSE:NVS - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 9,938 shares of the company's stock, valued at approximately $967,000.February 11, 2025 | marketbeat.comNovartis agrees to acquire Anthos for up to $3.1 blnFebruary 11, 2025 | reuters.comNovartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfrontFebruary 11, 2025 | globenewswire.comIs Novartis AG (NVS) The Best Annual Dividend Stock To Buy Now?February 10, 2025 | finance.yahoo.comArlington Partners LLC Sells 6,404 Shares of Novartis AG (NYSE:NVS)Arlington Partners LLC decreased its holdings in shares of Novartis AG (NYSE:NVS - Free Report) by 17.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 31,152 shares of the company's stoFebruary 10, 2025 | marketbeat.comElser Financial Planning Inc Acquires Shares of 8,978 Novartis AG (NYSE:NVS)Elser Financial Planning Inc purchased a new position in shares of Novartis AG (NYSE:NVS - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 8,978 shares of the company's stock, valued at approximately $874February 10, 2025 | marketbeat.comStrategic Financial Concepts LLC Invests $2.59 Million in Novartis AG (NYSE:NVS)Strategic Financial Concepts LLC bought a new stake in Novartis AG (NYSE:NVS - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 26,622 shares of the company's stock, valued at approFebruary 10, 2025 | marketbeat.comNovartis (NYSE:NVS) Raised to "Strong-Buy" at StockNews.comStockNews.com raised shares of Novartis from a "buy" rating to a "strong-buy" rating in a research report on Saturday.February 8, 2025 | marketbeat.comTriasima Portfolio Management inc. Reduces Holdings in Novartis AG (NYSE:NVS)Triasima Portfolio Management inc. lowered its position in shares of Novartis AG (NYSE:NVS - Free Report) by 36.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 20,498 shares of the company's stocFebruary 7, 2025 | marketbeat.com Get Novartis News Delivered to You Automatically Sign up to receive the latest news and ratings for NVS and its competitors with MarketBeat's FREE daily newsletter. Email Address NVS Media Mentions By Week NVS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVS News Sentiment▼1.360.60▲Average Medical News Sentiment NVS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVS Articles This Week▼2613▲NVS Articles Average Week Get Novartis News Delivered to You Automatically Sign up to receive the latest news and ratings for NVS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NVO News AZN News SNY News GSK News TAK News ARGX News BNTX News TEVA News SMMT News GMAB News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NVS) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novartis AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Novartis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
